Back
Top 0.3%
17.0%
#1
10.6%
Top 17%
6.2%
Top 49%
5.7%
#1
5.7%
Top 83%
4.8%
#1
4.8%
Top 0.8%
4.0%
Top 3%
3.7%
Top 2%
3.7%
Top 15%
3.0%
Top 2%
2.9%
Top 7%
1.9%
Top 8%
1.9%
Top 0.2%
1.5%
Top 5%
1.3%
Top 15%
1.3%
Top 20%
0.7%
Top 32%
0.7%
Top 14%
0.7%
Top 1%
0.7%
Top 1%
0.7%
Impaired Humoral and Cellular Immunity after SARS-CoV2 BNT162b2 (Tozinameran) Prime-Boost Vaccination in Kidney Transplant Recipients
2021-04-07
transplantation
Title + abstract only
View on medRxiv
Show abstract
Novel mRNA-based vaccines have been proven powerful tools to combat the global pandemic caused by SARS-CoV2 with BNT162b2 efficiently protecting individuals from COVID-19 across a broad age range. Still, it remains largely unknown how renal insufficiency and immunosuppressive medication affect development of vaccine induced immunity. We therefore comprehensively analyzed humoral and cellular responses in kidney transplant recipients after prime-boost vaccination with BNT162b2. As opposed to all ...
Predicted journal destinations
1
Frontiers in Immunology
140 training papers
2
Journal of Clinical Investigation
50 training papers
3
Nature Communications
483 training papers
4
Scientific Reports
701 training papers
5
Cell Reports Medicine
49 training papers
6
PLOS ONE
1737 training papers
7
Science Translational Medicine
40 training papers
8
Journal of the American Society of Nephrology
19 training papers
9
Vaccines
131 training papers
10
JCI Insight
63 training papers
11
eLife
262 training papers
12
iScience
74 training papers
13
The Journal of Infectious Diseases
137 training papers
14
Frontiers in Medicine
99 training papers
15
npj Vaccines
18 training papers
16
eBioMedicine
82 training papers
17
Journal of Clinical Medicine
77 training papers
18
Nature Medicine
88 training papers
19
JAMA Network Open
125 training papers
20
Journal of Medical Virology
95 training papers
21
Annals of Internal Medicine
27 training papers
22
EBioMedicine
21 training papers